Goldman Sees 100 IPOs Worth $160B in 2026

Goldman Sachs projects 100 initial public offerings totalling $160 billion will reach the market in 2026, a forecast the bank set out in a note reported on April 25, 2026 (Investing.com; Goldman Sachs, Apr 25, 2026). That scale, if realized, would represent a material reacceleration of primary issuance compared with the muted calendars of 2024–25 and would reshape capital allocation in growth sectors and financial services corridors. The prognosis matters for trading desks, asset allocators and corporate issuers: a sizable supply of new float can compress secondary liquidity, alter valuation multiples for public comparables and feed into bank fees for underwriting and secondary-market trading. This analysis dissects the Goldman forecast, places it in historical context, quantifies the potential market effects using established benchmarks, and identifies sector-level winners and risks.

Context

Goldman’s April 2026 forecast — 100 IPOs totaling $160 billion — was circulated internally and summarised publicly on April 25, 2026 (Investing.com; Goldman Sachs, Apr 25, 2026). The bank frames the expectation around an easing of macro policy risk, a backlog of pre-cleared filings, and an improving volatility environment that would allow issuers to tolerate the timing and pricing mechanics of primary issuance. For institutional desks that underwrite or provide aftermarket liquidity, the headline number is a proxy for fee pools: $160 billion of IPO proceeds implies tens of billions of dollars of underwriting spread and follow-on trading volume over the subsequent 6–12 months, depending on deal structure and lock-ups.

Historically, the cadence of IPOs is lumpy. Academic literature and market practitioners note that issuance clusters when volatility (as measured by VIX) falls and buy-side risk appetite expands. Average first-day return or 'pop' has been materially positive over decades; Loughran and Ritter reported historically high initial returns — on average in the mid-to-high teens — which feeds issuer timing decisions (Loughran & Ritter, 1997). That dynamic means that a surge of supply can both attract speculative demand and compress longer-term returns for early investors if broader market multiples reset.

The Goldman projection should be interpreted alongside operational constraints that shape execution. Typical IPO lock-up periods are frequently 90–180 days, materially affecting floating supply after listing (corporate prospectuses; common SEC practice). As lock-ups expire, secondary selling pressure can add to the initial period of elevated volatility; route-to-market decisions (direct listings, SPAC conversions, or traditional book-builds) will influence the immediate and residual supply dynamics.

Data Deep Dive

The headline pair of numbers — 100 deals, $160 billion proceeds — is the primary datum from Goldman (Investing.com reporting Goldman Sachs, Apr 25, 2026). Breaking that down: an average deal size implied by the forecast is $1.6 billion per IPO. That average would be significantly larger than the medians seen in the small-cap IPO market and implies a heavy skew toward large-cap or jumbo listings in sectors where private valuations have scaled (e.g., late-stage technology, healthcare platforms, energy transition companies). If even half the proceeds come from deals >$2.5 billion, underwriting syndicates and bookrunners will capture concentrated fee pools.

Comparative metrics matter. An average implied deal of $1.6 billion should be contrasted with the micro- and small-cap IPO cohorts where deal sizes are sub-$200 million; a shift to fewer, larger offerings alters the securities lending and market-making economics. Goldman’s estimate does not, in the published summary, disclose sectoral splits; however, a handful of large listings (>$5bn) materially moves the aggregate. If, for instance, ten jumbo deals of $5bn each materialize, they would account for $50bn — roughly one-third of the $160bn forecast — leaving the remainder distributed across mid- and small-size issues.

Timing is critical. Goldman’s note — dated April 2026 — references market conditions expected through 2026 and implicitly assumes volatility and rate trajectories that permit an orderly book-build process (Goldman Sachs, Apr 2026). Execution schedules suggest concentration in H2 2026 for many issuers; seasonality combined with backlog clear-outs can create crowded windows. That concentration can produce day-to-day dispersion in aftermarket returns: a crowded week could lower relative demand per deal and increase first-week volatility for new issues.

Sector Implications

Sectors with extended private funding cycles stand to supply the bulk of any 2026 issuance. Software, artificial intelligence infrastructure, specialized healthcare platforms (biotech with near-term revenue paths), and energy transition companies that have reached scale are the most likely to produce large-cap listings. A $160bn pipeline dominated by these sectors would shift public-market exposure to growth assets, potentially increasing sectoral correlations in equity indices. For index constructors and passive managers, new large floats can prompt reweights and track-tracking-error considerations when big-cap listings enter benchmarks.

Banking and capital markets desks will benefit from increased underwriting fees and aftermarket trading volumes. Major underwriters such as Goldman Sachs (ticker: GS) typically see fee income and equity trading flow when issuance expands. Conversely, market makers in small-cap names may see unchanged or reduced activity if the new supply is concentrated in larger names. For exchange operators (e.g., Nasdaq, NDAQ) and custody providers, listing fees and post-listing processing will generate measurable revenue; a calendar of 100 listings is staggered but meaningful for annualized fee pools.

From a valuation perspective, an influx of new public comparables can compress private-company valuations, particularly if IPO pricing resets perceived multiple ceilings. Private markets price discovery may accelerate if late-stage investors prefer liquidity windows; this can create a feedback loop that affects private fundraising terms and secondary market activity for pre-IPO shares.

Risk Assessment

Execution risk is the primary caveat. A forecast of 100 IPOs and $160bn presupposes stable or improving volatility and interest-rate expectations; a sudden macro shock or tightening in credit markets could force deferrals. Liquidity risk is another consideration: if deals cluster, the marginal demand for new float falls, raising the cost of capital for issuers and potentially lowering initial pricing. Market depth in sectors with heavy issuance will be tested — order book depth could be shallower than historical averages if market makers rebalance risk limits.

Underpricing and lock-up expiries represent additional downside scenarios for aftermarket investors. If initial returns follow historical norms (Loughran & Ritter-style first-day mean returns in the mid-to-high teens historically), some issuance will be driven by investor demand for short-term gains rather than long-term allocation, increasing volatility post-listing. Meanwhile, lock-up expiries at 90–180 days can create concentrated selling windows where founders and early investors harvest liquidity, adding to supply risk (company prospectuses; SEC filings).

Regulatory and geopolitical spillovers remain non-trivial. Cross-border listings, for example, may face intensified scrutiny on disclosure and governance that can delay or reduce deal size. Tax-law changes and market-structure reforms in key jurisdictions could also alter the net proceeds available to issuers and the attractiveness of public listings versus private routes.

Outlook

If Goldman’s forecast materializes, 2026 will likely mark a visible recovery in primary markets, restoring a pipeline that can feed secondary-market turnover for 12–18 months post-listing. For institutional allocators, this suggests tactical windows to access IPO allocations while also preparing for potential mean reversion in post-IPO performance. Strategically, managers should model scenarios where 20–40% of the $160bn comes via jumbo deals (> $2.5bn) versus a more distributed outcome dominated by mid-cap transactions.

For market structure, increased issuance will test liquidity-provision frameworks and securities finance capacity. Where significant float enters the market, securities lending desks may see upward pressure on borrow demand for newly listed names, at least through the 180-day lock-up period and into the first sizable secondary placements. Exchanges and underwriting banks will need to calibrate capacity for listing workstreams and after-market stabilization activities.

Fazen Markets Perspective

A contrarian read is that the headline $160bn is as important for signaling issuer confidence as it is for absolute supply. Large forecasts from a leading underwriter like Goldman can act as a self-fulfilling catalyst: management teams and private investors waiting for a market window may move to list because the forecast lowers perceived market-timing risk. That said, the average implied deal size of $1.6bn hides distributional risk — if the realized mix tilts to smaller-than-expected issues, underwriting economics and aftermarket dynamics will look materially different. Institutional participants should not treat the $160bn as an unconditional expansion of investable equity capacity; instead, model skewed distributions (heavy tail of large deals or, conversely, many sub-$500m listings) and stress-test portfolios across those paths. For deeper coverage on issuance mechanics and historical issuance cycles, see our equity issuance hub topic and related market-structure research topic.

FAQ

Q: How should investors think about IPO lock-up expiries in 2026?

A: Lock-up expiries typically fall between 90 and 180 days after pricing (company prospectuses and standard practice). For a large issuance calendar in H2 2026, many lock-ups would expire in early 2027, concentrating potential selling pressure. Historically, concentrated lock-up expiries can depress near-term share performance for affected issuers; investors should monitor scheduled expiries in prospectuses and model potential supply shocks against typical daily average volumes.

Q: Could a $160bn IPO pipeline change private-market valuations?

A: Yes. A credible, visible route to public markets reduces the liquidity premium private investors require; this can compress late-stage private valuations if issuers and investors choose to capture public-market liquidity sooner. Conversely, if the public window is crowded or underpriced, private-market participants may delay exits, preserving higher private valuations — the direction depends on pricing dynamics and investor risk tolerance.

Bottom Line

Goldman’s projection of 100 IPOs totaling $160bn for 2026 signals a potentially material return of primary-market activity, but execution, distribution of deal sizes, and macro volatility will determine whether the forecast becomes a market-transforming reality.

Disclaimer: This article is for informational purposes only and does not constitute investment advice.